Importantly, this reduced need for endogenous insulin, termed as the “insulin sparing action” may be exploited to help prevent pancreatic β cell damage, which is a common progression from insulin resistance E4orf1-based strategy might reduce hyperinsulinemia of insulin resistance and thereby, prevent or delay β cell failure. Here, INS is linked to hyperinsulinism.